NTLA
Intellia Therapeutics, Inc. · Healthcare
Director John F Crowley sold $1.3M of Intellia Therapeutics, Inc.
Sold$1,305,391
$130.54Price
10,000Shares
−83%Stake
What NTLA did after the filing
- The stock from Thu, Oct 7 close, $134.78
- +0.1%
- S&P 500, same days
- +7.1%
Measured over 30 trading days, to the Nov 18 close.
Traded Tue, Oct 5. Filed Thu, Oct 7, 1:41 PM ET, during the session. Returns use the Oct 7 close and the Nov 18 close. Not investment advice.